Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBNX NASDAQ:ESTA NASDAQ:TMDX NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$15.85-1.7%$14.41$8.80▼$32.71$706.28M3.041.12 million shs558,667 shsESTAEstablishment Labs$92.32+1.3%$82.05$33.35▼$96.99$2.72B1.06550,979 shs207,626 shsTMDXTransMedics Group$72.26+1.6%$71.55$60.10▼$156.00$2.50B1.891.08 million shs1.14 million shsWRBYWarby Parker$24.53+0.9%$26.41$14.96▼$31.00$2.63B1.913.16 million shs2.16 million shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics-1.10%-4.56%+18.00%+44.40%+9.21%ESTAEstablishment Labs-2.95%-1.30%+4.70%+37.45%+110.98%TMDXTransMedics Group-0.10%-6.41%-3.66%-35.88%-35.32%WRBYWarby Parker-0.65%-11.82%-5.26%+6.58%-0.11%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$15.85-1.7%$14.41$8.80▼$32.71$706.28M3.041.12 million shs558,667 shsESTAEstablishment Labs$92.32+1.3%$82.05$33.35▼$96.99$2.72B1.06550,979 shs207,626 shsTMDXTransMedics Group$72.26+1.6%$71.55$60.10▼$156.00$2.50B1.891.08 million shs1.14 million shsWRBYWarby Parker$24.53+0.9%$26.41$14.96▼$31.00$2.63B1.913.16 million shs2.16 million shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics-1.10%-4.56%+18.00%+44.40%+9.21%ESTAEstablishment Labs-2.95%-1.30%+4.70%+37.45%+110.98%TMDXTransMedics Group-0.10%-6.41%-3.66%-35.88%-35.32%WRBYWarby Parker-0.65%-11.82%-5.26%+6.58%-0.11%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBNXBeta Bionics 2.64Moderate Buy$20.3025.58% UpsideESTAEstablishment Labs 2.67Moderate Buy$90.43-3.07% DownsideTMDXTransMedics Group 2.38Hold$134.5090.93% UpsideWRBYWarby Parker 2.67Moderate Buy$29.8220.99% UpsideCurrent Analyst Ratings BreakdownLatest BBNX, WRBY, ESTA, and TMDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/22/2026TMDXTransMedics Group Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight7/17/2026BBNXBeta Bionics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/15/2026ESTAEstablishment Labs MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$100.00 ➝ $105.007/15/2026BBNXBeta Bionics The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$17.00 ➝ $19.007/13/2026BBNXBeta Bionics Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$18.00 ➝ $22.007/13/2026ESTAEstablishment Labs BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy7/8/2026ESTAEstablishment Labs CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$76.00 ➝ $92.007/6/2026TMDXTransMedics Group Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell7/1/2026TMDXTransMedics Group TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$120.006/30/2026TMDXTransMedics Group Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$124.006/29/2026WRBYWarby Parker Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$33.00(Data available from 7/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBNXBeta Bionics$100.25M7.19N/AN/A$6.53 per share2.48ESTAEstablishment Labs$211.08M13.01N/AN/A$0.81 per share115.18TMDXTransMedics Group$605.49M4.02$3.89 per share18.13$13.79 per share5.11WRBYWarby Parker$871.91M3.03$0.63 per share39.02$3.48 per share7.08Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBNXBeta Bionics-$73.20M-$1.51N/AN/AN/A-60.27%-23.00%-20.55%N/AESTAEstablishment Labs-$51.06M-$1.49N/A666.41N/A-19.05%-218.77%-12.31%8/6/2026 (Estimated)TMDXTransMedics Group$190.29M$4.4016.0321.74N/A27.04%22.38%8.46%7/29/2026 (Estimated)WRBYWarby Parker$1.64M$0.021,235.8761.624.910.15%2.30%1.18%8/6/2026 (Estimated)Latest BBNX, WRBY, ESTA, and TMDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026ESTAEstablishment Labs-$0.34N/AN/AN/A$65.79 millionN/A8/6/2026Q2 2026WRBYWarby Parker$0.12N/AN/AN/A$237.98 millionN/A7/29/2026Q2 2026TMDXTransMedics Group$0.50N/AN/AN/A$183.79 millionN/A5/7/2026Q1 2026ESTAEstablishment Labs-$0.3550-$0.45-$0.0951-$0.45$57.40 million$59.88 million5/7/2026Q1 2026WRBYWarby Parker$0.11$0.03-$0.08$0.03$239.44 million$242.45 million5/5/2026Q1 2026TMDXTransMedics Group$0.62$0.30-$0.32$0.20$174.44 million$173.93 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBBNXBeta BionicsN/AN/AN/AN/AN/AESTAEstablishment LabsN/AN/AN/AN/AN/ATMDXTransMedics GroupN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBNXBeta BionicsN/A10.699.67ESTAEstablishment Labs16.822.961.91TMDXTransMedics Group1.706.746.19WRBYWarby ParkerN/A2.332.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBNXBeta BionicsN/AESTAEstablishment Labs72.91%TMDXTransMedics Group99.67%WRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipBBNXBeta Bionics5.30%ESTAEstablishment Labs9.99%TMDXTransMedics Group6.90%WRBYWarby Parker16.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBNXBeta Bionics29444.56 million42.20 millionN/AESTAEstablishment Labs1,00429.43 million26.49 millionOptionableTMDXTransMedics Group21034.56 million32.18 millionOptionableWRBYWarby Parker4,036107.09 million89.10 millionOptionableBBNX, WRBY, ESTA, and TMDX HeadlinesRecent News About These CompaniesAtika Capital Management LLC Sells 113,971 Shares of Warby Parker Inc. $WRBYJuly 24 at 3:24 AM | marketbeat.comWarby Parker (NYSE:WRBY) Stock Price Down 6.1% - Here's WhyJuly 20, 2026 | marketbeat.comWarby Parker (WRBY) Stock Still Looks Pricey Following Its 85% RiseJuly 18, 2026 | finance.yahoo.comWarby Parker (WRBY) Faces A 12% Fair Value Gap Following Q2 Earnings Date SetJuly 18, 2026 | finance.yahoo.comWarby Parker to Announce Second Quarter 2026 Financial Results on August 6, 2026July 16, 2026 | finance.yahoo.comWarby Parker Inc. (NYSE:WRBY) Receives Average Recommendation of "Moderate Buy" from AnalystsJuly 16, 2026 | americanbankingnews.comWarby Parker Inc. (NYSE:WRBY) Given Consensus Rating of "Moderate Buy" by BrokeragesJuly 16, 2026 | marketbeat.comNeil Harris Blumenthal Sells 9,200 Shares of Warby Parker (NYSE:WRBY) StockJuly 9, 2026 | insidertrades.comWarby Parker (NYSE:WRBY) CEO Neil Harris Blumenthal Sells 9,200 SharesJuly 8, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) Trading Down 6.3% - What's Next?July 8, 2026 | marketbeat.comSimplify Asset Management Inc. Sells 109,512 Shares of Warby Parker Inc. $WRBYJuly 4, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) CEO Sells 217,667 SharesJuly 3, 2026 | insidertrades.comInsider Selling: Warby Parker (NYSE:WRBY) CEO Sells 217,667 SharesJuly 2, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) CEO Sells $1,090,452.00 in StockJuly 2, 2026 | insidertrades.comNeil Harris Blumenthal Sells 36,300 Shares of Warby Parker (NYSE:WRBY) StockJuly 1, 2026 | marketbeat.comSG Americas Securities LLC Invests $2.71 Million in Warby Parker Inc. $WRBYJuly 1, 2026 | marketbeat.comWarby Parker disrupts eyewear industry with full-service eyewear retailer — BofAJune 29, 2026 | seekingalpha.comWarby Parker Has 'Plenty More Than Meets The Eye', Analyst SaysJune 29, 2026 | benzinga.comWarby Parker (NYSE:WRBY) Coverage Initiated by Analysts at Bank of AmericaJune 29, 2026 | marketbeat.comMaridea Wealth Management LLC Raises Holdings in Warby Parker Inc. $WRBYJune 27, 2026 | marketbeat.comWhat Does the Sale of Warby Parker Shares Worth $1.9 Million by the Co-CEO Mean for Investors?June 25, 2026 | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesEnergy Fuels Just Made a Bold Bet on Rare Earth MagnetsBy Jeffrey Neal Johnson | June 25, 2026Domino's Stock Slides to 52-Week Low as Investors Digest CEO ChangeBy Jennifer Ryan Woods | June 25, 2026New Stock Price Highs Are on the Menu for Darden RestaurantsBy Thomas Hughes | June 29, 2026Burger King’s Turnaround Is Putting Restaurant Brands Back in FocusBy Peter Frank | July 1, 2026Confidence Is Back, But Earnings Show the Consumer Is Being PickyBy Jessica Mitacek | July 21, 2026BBNX, WRBY, ESTA, and TMDX Company DescriptionsBeta Bionics NASDAQ:BBNX$15.85 -0.28 (-1.74%) Closing price 04:00 PM EasternExtended Trading$16.12 +0.28 (+1.74%) As of 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.Establishment Labs NASDAQ:ESTA$92.32 +1.22 (+1.34%) Closing price 04:00 PM EasternExtended Trading$92.32 0.00 (0.00%) As of 05:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.TransMedics Group NASDAQ:TMDX$72.26 +1.13 (+1.59%) Closing price 04:00 PM EasternExtended Trading$71.76 -0.50 (-0.69%) As of 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.Warby Parker NYSE:WRBY$24.52 +0.22 (+0.88%) Closing price 03:59 PM EasternExtended Trading$24.18 -0.35 (-1.43%) As of 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Plugging In: How Kinder Morgan Powers Up Profits TSMC’s Price Hikes Could Show Which AI Chip Stocks Have Real Pricing Power AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
